Clariant is expanding its Clear Lake facility to manufacture pharmaceutical-grade polyethylene glycol excipients under GMP standards.
The move strengthens regional supply security, shortens lead times and improves continuity for North American and Latin American drugmakers, supporting the company’s strategy to grow its healthcare and excipients business.